Last News

Tambre presents two innovative studies at the ESHRE fertility and embryology congress in Amsterdam

Clinica Tambre is taking part in the ESHRE 2024 Human Reproduction and Embryology congress, which is held between the 7th and 10th July in Amsterdam. This event is the most important in the field of fertility in Europe and this year celebrates its 40th anniversary.

Members of the team, accompanied by our CEO Inge Kormelink, Scientific Director Dr. Ángela Llaneza, embryologist Raquel García and Scientific Advisor José Horcajadas, will present two innovative studies developed by the Tambre Foundation and learn about the latest developments from the world’s leading infertility specialists.

The congress enables the Foundation to fulfil one of its objectives, which is to promote research, innovation and scientific progress in fertility and assisted reproduction.

The Tambre Study’s

Probiotic Treatment and Pregnancy Rates

This study evaluates the impact of probiotic treatment in patients with different Lactobacillus species in the endometrium. Implantation and clinical pregnancy rates were high, highlighting the importance of rebalancing the endometrial microbiota to improve fertility outcomes.


Evaluation of pregnancy rates post-probiotic treatment in patients with varied Lactobacillus species in pre-transfer endometrial microbiome analysis

García L., Beltrán J, Díaz-López C., Campos D., Horcajadas J. A., Llaneza A

Innovation and personalised attentionAt Clinica Tambre, we offer innovative treatments backed by the most advanced technology and the experience of a multidisciplinary team. Our approach includes:Cutting-edge treatments. We are constantly training and researching to offer the most advanced treatments.Use of advanced technology to maximise the chances of success.A Multidisciplinary and empathetic team that provides constant support and helps resolve patient anxieties, questions and concerns.Personalised attention – each patient is assigned a doctor and an expert fertility consultant, guaranteeing continuous and exclusive attention.Tambre regularly attends the most important scientific meetings in the world.We offer the most advanced reproductive medicine.We are different because

    • We focus on the value of diagnosis to identify the causes of infertility.
    • We offer advanced treatments using state-of-the-art technology including artificial intelligence, which allows us to save time and be more precise in the processes.
    • Continuous research in collaboration with universities and international organisations
    • Holistic vision: our team is multidisciplinary and includes gynaecologists, fertility experts, biologists, embryologists, geneticists, urologists, psychologists, and nurses.
  • Personalised treatments and tailor-made treatment design
  • Continuous follow-up of the patient during the treatment with two constants: your doctor and your personal assistant.
  • Continuous information to the patient in their own language
  • Own gamete bank
  • International and multilingual team
  • No waiting list

We turn dreams into reality, supporting each patient on their journey to parenthood with the latest scientific advances and a warm, personalised approach. Find out why we are the ideal place for your fertility treatment. At Tambre, dreams can become reality.

Sperm Selection by Microfluidics (ZyMot-ICSI®)


This study investigates how the ZyMot-ICSI® sperm selection technique influences the genetic quality of embryos. The study observed that this technique decreased the number of embryos with alterations in their chromosomes (aneuploids) and increased the number of chromosomally normal embryos (euploids) and mosaics, which are those that have a mixture of normal cells and cells with chromosomal abnormalities, potentially improving success rates in fertility treatments.


Euploidy and mosaics rates using Microfluid Sperm Selection Techniques (ZyMot -ICSI®)

Cortés S, Arasa M, Andrés C., Cordero C., Rodríguez-Roque C., Almoyna A., Navarro H., Horcajadas J.A.